Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDK4/6
Pharma
Novartis pressures Lilly with Kisqali's broad breast cancer nod
The expanded label separates Novartis' Kisqali from Eli Lilly's Verzenio by covering patients who don't have cancer cells in their lymph nodes.
Angus Liu
Sep 17, 2024 3:04pm
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
May 23, 2024 5:00pm
ASCO: Novartis details Kisqali's adjuvant breast cancer win
Jun 2, 2023 8:00am
ASCO: Merck, Novartis to face moment of truth in early cancers
May 25, 2023 3:23pm
Novartis' Kisqali, Pluvicto top list of investor concerns
Apr 25, 2023 11:22am
Eyeing Lilly, Novartis touts broader adjuvant breast cancer win
Mar 27, 2023 11:20am
